Literature DB >> 32042617

Editorial comment: understanding the cost of bladder preservation in muscle invasive bladder cancer-an evaluation of radical cystectomy versus trimodal therapy costs.

Diana E Magee1, Girish S Kulkarni1.   

Abstract

Entities:  

Year:  2019        PMID： 32042617      PMCID： PMC6989857          DOI： 10.21037/tau.2019.10.09

Source DB:  PubMed          Journal:  Transl Androl Urol        ISSN： 2223-4683


× No keyword cloud information.
  15 in total

1.  Canadian Urological Association guideline: Muscle-invasive bladder cancer.

Authors:  Girish S Kulkarni; Peter C Black; Srikala S Sridhar; Anil Kapoor; Alexandre R Zlotta; Bobby Shayegan; Ricardo A Rendon; Peter Chung; Theodorus van der Kwast; Nimira Alimohamed; Yves Fradet; Wassim Kassouf
Journal:  Can Urol Assoc J       Date:  2019-01-31       Impact factor: 1.862

2.  Trimodal Therapy is Inferior to Radical Cystectomy for Muscle-invasive Bladder Cancer using Population-level Data: Is There Evidence in the (Lack of) Details?

Authors:  Girish S Kulkarni; Zachary Klaassen
Journal:  Eur Urol       Date:  2017-05-06       Impact factor: 20.096

3.  Comparison of Costs of Radical Cystectomy vs Trimodal Therapy for Patients With Localized Muscle-Invasive Bladder Cancer.

Authors:  Stephen B Williams; Yong Shan; Mohamed D Ray-Zack; Hogan K Hudgins; Usama Jazzar; Douglas S Tyler; Stephen J Freedland; Todd A Swanson; Jacques G Baillargeon; Jim C Hu; Sapna Kaul; Ashish M Kamat; John L Gore; Hemalkumar B Mehta
Journal:  JAMA Surg       Date:  2019-08-21       Impact factor: 14.766

4.  Propensity Score Analysis of Radical Cystectomy Versus Bladder-Sparing Trimodal Therapy in the Setting of a Multidisciplinary Bladder Cancer Clinic.

Authors:  Girish S Kulkarni; Thomas Hermanns; Yanliang Wei; Bimal Bhindi; Raj Satkunasivam; Paul Athanasopoulos; Peter J Bostrom; Cynthia Kuk; Kathy Li; Arnoud J Templeton; Srikala S Sridhar; Theodorus H van der Kwast; Peter Chung; Robert G Bristow; Michael Milosevic; Padraig Warde; Neil E Fleshner; Michael A S Jewett; Shaheena Bashir; Alexandre R Zlotta
Journal:  J Clin Oncol       Date:  2017-04-14       Impact factor: 44.544

5.  Comparative Effectiveness of Trimodal Therapy Versus Radical Cystectomy for Localized Muscle-invasive Urothelial Carcinoma of the Bladder.

Authors:  Thomas Seisen; Maxine Sun; Stuart R Lipsitz; Firas Abdollah; Jeffrey J Leow; Mani Menon; Mark A Preston; Lauren C Harshman; Adam S Kibel; Paul L Nguyen; Joaquim Bellmunt; Toni K Choueiri; Quoc-Dien Trinh
Journal:  Eur Urol       Date:  2017-04-12       Impact factor: 20.096

6.  Clinical model of cost of bladder cancer in the elderly.

Authors:  Catherine D Cooksley; Elenir B C Avritscher; H Barton Grossman; Anita L Sabichi; Colin P Dinney; Curtis Pettaway; Linda S Elting
Journal:  Urology       Date:  2008-03       Impact factor: 2.649

Review 7.  The burden of bladder cancer care: direct and indirect costs.

Authors:  Matthew Mossanen; John L Gore
Journal:  Curr Opin Urol       Date:  2014-09       Impact factor: 2.309

8.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

9.  Trimodality bladder preservation therapy for muscle-invasive bladder cancer.

Authors:  Ronald C Chen; William U Shipley; Jason A Efstathiou; Anthony L Zietman
Journal:  J Natl Compr Canc Netw       Date:  2013-08       Impact factor: 11.908

10.  Phase-specific and lifetime costs of cancer care in Ontario, Canada.

Authors:  Claire de Oliveira; Reka Pataky; Karen E Bremner; Jagadish Rangrej; Kelvin K W Chan; Winson Y Cheung; Jeffrey S Hoch; Stuart Peacock; Murray D Krahn
Journal:  BMC Cancer       Date:  2016-10-18       Impact factor: 4.430
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.